Lee Johnson Capital Management LLC Invests $203,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Lee Johnson Capital Management LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 342 shares of the biotechnology company’s stock, valued at approximately $203,000. Axon Enterprise comprises about 0.1% of Lee Johnson Capital Management LLC’s investment portfolio, making the stock its 29th biggest holding.

Several other large investors have also recently added to or reduced their stakes in AXON. Quent Capital LLC raised its stake in Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after purchasing an additional 75 shares during the period. Prestige Wealth Management Group LLC increased its holdings in shares of Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the last quarter. Brooklyn Investment Group purchased a new position in shares of Axon Enterprise in the 3rd quarter worth $41,000. Planning Capital Management Corp raised its position in shares of Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the period. Finally, Friedenthal Financial acquired a new position in Axon Enterprise in the third quarter valued at $51,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 50,545 shares of company stock valued at $30,721,337. Insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Up 1.4 %

Shares of Axon Enterprise stock opened at $593.89 on Monday. Axon Enterprise, Inc. has a 1-year low of $247.04 and a 1-year high of $698.67. The company has a market capitalization of $45.28 billion, a PE ratio of 153.46, a P/E/G ratio of 5.71 and a beta of 1.04. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business has a 50-day moving average of $617.37 and a 200-day moving average of $461.15.

Analyst Upgrades and Downgrades

Several brokerages have commented on AXON. Needham & Company LLC upped their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Robert W. Baird increased their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, JMP Securities raised their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $504.92.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.